Delisting of Securities of Tapestry Pharmaceuticals, Inc. (TPPH) From The NASDAQ Stock Market
5/1/2008 11:25:40 AM
More...
|
Tapestry Pharmaceuticals, Inc. (TPPH) Receives Nasdaq Delisting Notice
4/9/2008 8:40:10 AM
More...
|
Tapestry Pharmaceuticals, Inc. (TPPH) Receives Notice Regarding Minimum Bid Price Rule
12/26/2007 8:07:43 AM
More...
|
Eric Rowinsky, M.D. and Martin Cannon Join Tapestry Pharmaceuticals, Inc. (TPPH) Board of Directors
12/5/2007 11:06:00 AM
More...
|
Tapestry Pharmaceuticals, Inc. (TPPH) Reports Third Quarter 2007 Financial Results and Preliminary Data From Its Phase 2 Prostate Cancer Trial
11/5/2007 7:20:10 AM
More...
|
Tapestry Pharmaceuticals, Inc. (TPPH) to Host Conference Call on November 5th to Discuss Third Quarter 2007 Financial Results
10/30/2007 8:27:03 AM
More...
|
Tapestry Pharmaceuticals, Inc. (TPPH) to Host Conference Call on November 5th to Discuss Third Quarter 2007 Financial Results
10/29/2007 7:13:46 AM
More...
|
Tapestry Pharmaceuticals, Inc. (TPPH) Announces Strategy to Focus on TPI 287 Clinical Program; Company Downsizing Non-clinical Workforce
10/26/2007 6:44:44 AM
More...
|
Tapestry Pharmaceuticals, Inc. (TPPH) Presents Data on TPI 287 at the AACR-NCI-EORTC International Conference
10/24/2007 7:15:46 AM
More...
|
Tapestry Pharmaceuticals, Inc. (TPPH) Initiates Phase 2 Trial of TPI 287 for the Treatment of Advanced Pancreatic Cancer
10/3/2007 7:32:56 AM
More...
|
|